APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE ε4 on Alzheimer’s Disease Risk in a Multiracial SampleKyu Choi, Gyungah Jun, Kathryn L. Lunetta et al.|Journal of Clinical Medicine|2019Cited by 76
Diagnostic Blood Biomarkers in Alzheimer’s DiseaseJung-Eun Park, Byeong C. Kim, Tamil Iniyan Gunasekaran et al.|Biomedicines|2022Cited by 46
Potential Novel Genes for Late-Onset Alzheimer’s Disease in East-Asian Descent Identified by APOE-Stratified Genome-Wide Association StudySarang Kang, Kun Ho Lee, Jungsoo Gim et al.|Journal of Alzheimer s Disease|2021Cited by 38
A missense variant in SHARPIN mediates Alzheimer’s disease-specific brain damagesJun Young Park, Dongsoo Lee, Jang Jae Lee et al.|Translational Psychiatry|2021Cited by 20
Frequency of Microvascular Pathology and Hippocampal Atrophy on <scp>Magnetic Resonance Imaging</scp> in a Community Study of Alzheimer's Disease with Blood‐Based BiomarkersTamil Iniyan Gunasekaran, Richard Mayeux, Danurys Sanchez et al.|Annals of Neurology|2025Cited by 7